CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$11,000
+22.2%
15,5380.0%0.00%
Q3 2020$9,000
-93.7%
15,538
-91.9%
0.00%
Q2 2020$142,000
-51.0%
192,276
-38.0%
0.00%
Q1 2020$290,000
-53.5%
310,052
+1.5%
0.00%
Q4 2019$624,000
-15.3%
305,448
+19.0%
0.00%
Q3 2019$737,000
-60.8%
256,705
+4.6%
0.00%
-100.0%
Q2 2019$1,882,000
-55.8%
245,321
-23.5%
0.00%
-66.7%
Q1 2019$4,261,000
-14.3%
320,552
+0.4%
0.00%
-25.0%
Q4 2018$4,973,000
-22.3%
319,131
-2.0%
0.00%0.0%
Q3 2018$6,399,000
-32.6%
325,618
-1.6%
0.00%
-42.9%
Q2 2018$9,499,000
+37.3%
330,943
+13.1%
0.01%
+40.0%
Q1 2018$6,919,000
+6.5%
292,529
-3.4%
0.01%0.0%
Q4 2017$6,496,000
-2.8%
302,836
+7.1%
0.01%
-16.7%
Q3 2017$6,686,000
+3.4%
282,688
-13.9%
0.01%0.0%
Q2 2017$6,465,000
-20.6%
328,163
-15.3%
0.01%
-25.0%
Q1 2017$8,142,000
+12.5%
387,668
+0.7%
0.01%0.0%
Q4 2016$7,238,000
-23.9%
384,954
-15.4%
0.01%
-27.3%
Q3 2016$9,506,000
-29.3%
455,246
-13.7%
0.01%
-35.3%
Q2 2016$13,454,000
+28.6%
527,488
+33.4%
0.02%
+21.4%
Q1 2016$10,459,000
-55.5%
395,390
-28.0%
0.01%
-56.2%
Q4 2015$23,477,000
+66.6%
548,777
+3.2%
0.03%
+52.4%
Q3 2015$14,093,000
-20.5%
531,578
-0.0%
0.02%
-12.5%
Q2 2015$17,722,000
+2.0%
531,688
+1.8%
0.02%0.0%
Q1 2015$17,378,000
+20.7%
522,158
+48.2%
0.02%
+9.1%
Q4 2014$14,401,000
+221.3%
352,349
+166.4%
0.02%
+214.3%
Q3 2014$4,482,000
+6.2%
132,287
+5.7%
0.01%0.0%
Q2 2014$4,220,000
+1.5%
125,181
+14.1%
0.01%0.0%
Q1 2014$4,158,000
+33.5%
109,669
+2.8%
0.01%
+16.7%
Q4 2013$3,115,000
-33.0%
106,653
-18.7%
0.01%
-33.3%
Q3 2013$4,647,000
-27.9%
131,145
-29.4%
0.01%
-35.7%
Q2 2013$6,448,000185,7530.01%
Other shareholders

There were no reported owners of ACORDA THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of ACORDA THERAPEUTICS INC shareholders